MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
Gain Therapeutics, Inc. (NASDAQ: GANX)*
Organization & Developments: Gain Therapeutics
Parents
Gain Therapeutics, Inc. (NASDAQ: GANX)*
Children
*The firm is a pre-clinical biopharma developing treatment candidates for diseases caused by protein misfolding.
*The firm is a preclinical biopharma developing treatments for lysosomal storage disorders.
2021: GAIN THERAPEUTICS, INC. ANNOUNCES POSITIVE TOPLINE DATA IN PATIENT-DERIVED IPSC STUDY EVALUATING STAR COMPOUNDS AS A TREATMENT FOR GAUCHER AND PARKINSON’S DISEASE
2021: Gain Therapeutics: Shares Of Enzyme Therapy/Neurodegeneration Specialist Look Like A Surprisingly Good
2021: Gain Therapeutics: Shares Of Enzyme Therapy/Neurodegeneration Specialist Look Like A Surprisingly Good Value
2024: A biotech’s difficult journey to bring a new kind of Parkinson’s drug to patients
2024: A biotech’s difficult journey to bring a new kind of Parkinson’s drug to patients
2024: Gain Therapeutics Excels in Neurodegenerative Drug Trials_www.tipranks.com
2024: Gain Therapeutics Regains Nasdaq Compliance By Investing.com
2024: Gain Therapeutics: Parkinson's Drug Candidate GT-02287 Keeps Racking Up Good Results
2024: Gain Therapeutics: The Case For GCase In Parkinson's And Buyout Potential_seekingalpha.com
2024: Gain Therapeutics' Parkinson's Drug Shows 53% Activity Boost in Phase 1 Trial
Jumps
Finance & Acquisitions: Gain Therapeutics
Key People: Gain Therapeutics